Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

INFO

Published Date :

2025-12-02T21:07:47.995Z

Last Modified :

2025-12-09T17:03:27.576Z

Source :

icscert
AFFECTED PRODUCTS

The following products are affected by CVE-2025-61940 vulnerability.

Vendors Products
Microsoft
  • Windows
Mirion
  • Biodose\/nmis
Mirion Medical
  • Nmis Biodose
REFERENCES

Here, you will find a curated list of external links that provide in-depth information to CVE-2025-61940.

URL Resource
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01 cve-icon cve-icon
Login to claim this CVE

CVSS Vulnerability Scoring System

Detailed values of each vector for above chart.
Attack Vector
Attack Complexity
Attack Requirements
Privileges Required
User Interaction
VS Confidentiality
VS Integrity
VS Availability
SS Confidentiality
SS Integrity
SS Availability
Detailed values of each vector for above chart.
Attack Vector
Attack Complexity
Privileges Required
User Interaction
Scope
Confidentiality Impact
Integrity Impact
Availability Impact